...
机译:受体酪氨酸激酶A型环酪氨酸转磷酸化的分子基础
Nanjing Univ Sci &
Technol Sch Chem Engn Nanjing Peoples R China;
NYU Dept Chem New York NY 10016 USA;
NYU Sch Med Dept Biochem &
Mol Pharmacol New York NY 10016 USA;
NYU Dept Chem New York NY 10016 USA;
NYU Sch Med Dept Cell Biol New York NY 10016 USA;
Univ Rhode Isl Dept Cell &
Mol Biol Kingston RI 02881 USA;
NYU Sch Med Dept Biochem &
Mol Pharmacol New York NY 10016 USA;
NYU Sch Med Dept Biochem &
Mol Pharmacol New York NY 10016 USA;
Univ Rhode Isl Dept Cell &
Mol Biol Kingston RI 02881 USA;
NYU Dept Chem New York NY 10016 USA;
Nanjing Univ Sci &
Technol Sch Chem Engn Nanjing Peoples R China;
NYU Sch Med Dept Cell Biol New York NY 10016 USA;
Wenzhou Med Univ Sch Pharmaceut Sci Chem Biol Res Ctr Wenzhou Zhejiang Peoples R China;
NYU Dept Chem New York NY 10016 USA;
NYU Sch Med Dept Biochem &
Mol Pharmacol New York NY 10016 USA;
机译:受体酪氨酸激酶A型环酪氨酸转磷酸化的分子基础
机译:Asp816Val突变型KIT受体酪氨酸激酶的本构活性和STI571抗性的分子基础
机译:先天性无汗症疼痛的分子基础(CIPA):编码神经生长因子受体酪氨酸激酶的TRKA(NTRK1)基因的突变和多态性。
机译:羧基脚印MS为致癌癌癌患者的间晶酶激酶异二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二二草的结构见解提供结构洞察力
机译:模型哺乳动物膜中受体酪氨酸激酶二聚化的热力学:确定癌症和骨骼发育不良背后的分子基础。
机译:耐药性的分子基础:表皮生长因子受体酪氨酸激酶抑制剂和间变性淋巴瘤激酶抑制剂
机译:耐药物的分子基础:表皮生长因子受体酪氨酸激酶抑制剂和促进淋巴瘤激酶抑制剂